AngioDynamics, Inc. (ANGO) has a negative trailing P/E of -13.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 55.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -7.25%, forward earnings yield 1.81%. PEG 1.05.
Criteria proven by this page:
Overall SharesGrow Score: 40/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -9.9 | -0.01 | 0.85 | 1.22 | - |
| 2017 | -78.3 | 0.68 | 1.07 | 1.58 | - |
| 2018 | 47.7 | 0.36 | 1.44 | 2.26 | - |
| 2019 | 11.5 | 0.04 | 1.15 | 1.96 | - |
| 2020 | -2.4 | 0.01 | 0.86 | 1.49 | - |
| 2021 | -28.5 | 0.35 | 2.05 | 3.09 | - |
| 2022 | -28.8 | 1.69 | 1.80 | 2.42 | - |
| 2023 | -7.1 | -0.07 | 0.99 | 1.10 | - |
| 2024 | -1.4 | -0.01 | 1.23 | 0.83 | - |
| 2025 | -12.3 | 0.15 | 2.28 | 1.43 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-1.23 | $353.69M | $-44.45M | -12.6% |
| 2017 | $0.19 | $349.64M | $7.01M | 2% |
| 2018 | $0.44 | $344.29M | $16.34M | 4.7% |
| 2019 | $1.64 | $359.48M | $61.34M | 17.1% |
| 2020 | $-4.37 | $264.16M | $-165.79M | -62.8% |
| 2021 | $-0.82 | $291.01M | $-31.55M | -10.8% |
| 2022 | $-0.68 | $316.22M | $-26.55M | -8.4% |
| 2023 | $-1.33 | $338.75M | $-52.44M | -15.5% |
| 2024 | $-4.59 | $303.91M | $-184.35M | -60.7% |
| 2025 | $-0.83 | $292.5M | $-33.99M | -11.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.29 | $-0.30 – $-0.28 | $312.87M | $312.4M – $313.33M | 2 |
| 2027 | $-0.11 | $-0.13 – $-0.08 | $328.33M | $322.68M – $333.99M | 2 |
| 2028 | $0.21 | $0.21 – $0.21 | $346.2M | $345.7M – $346.7M | 1 |
| 2029 | $0.29 | $0.29 – $0.29 | $362.6M | $360.33M – $364.62M | 1 |
| 2030 | $0.34 | $0.34 – $0.34 | $380.8M | $378.42M – $382.93M | 1 |
